Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Ratan Capital bounces back in 2020 after years of curve balls

Published 02/23/2021, 01:19 PM
Updated 02/23/2021, 01:20 PM
© Reuters. FILE PHOTO: A Specialist trader watches his chart while working on the floor of the New York Stock Exchange

By Svea Herbst-Bayliss

BOSTON (Reuters) - A few years ago, Ratan Capital Management faced questions of survival due to bad bets that shriveled its capital and its founder settling regulatory charges about information sharing.

Now, the hedge fund is back in the spotlight after posting stellar returns last year that might help lure new investors.

Ratan Capital, run by Nehal Chopra, delivered a 98% return in 2020, its best ever, thanks to long-held investments in companies that provide business solutions, according to a letter sent to investors and seen by Reuters.

Its performance trounced the average hedge fund's 11.6% return, as well as the S&P 500 Index , which gained 16% last year.

Investments in Vertiv Holding Co, RingCentral (NYSE:RNG) Inc and Clarivate PLC were the biggest winners, all posting double-digit gains, Chopra wrote. They more than offset losses from online ticket-ordering business Trainline PLC and health-insurance claims processor Multiplan Corp.

Chopra declined to comment.

It is too early to know whether the outsize returns lead to fresh capital, but Ratan's performance is the latest in a series of dips and rebounds for the firm. One of a handful of women to run their own hedge funds, investors saw Chopra as a rising star when she started Ratan in 2009. It was a difficult time to launch because of industry losses during the financial crisis, but she secured backing from major investors including Tiger Management founder Julian Robertson.

Strong early results helped swell Ratan's assets to roughly $1 billion by 2015. Despite ups and downs, its long-term performance has been strong, with an average 16% return over 10 years and an average 35% return per year over the last three years.

However, Ratan joined prominent hedge fund managers, including Pershing Square Capital Management's William Ackman, to invest in pharmaceutical firm Valeant – which turned out to be a disastrous bet. Now called Bausch Health Companies (NYSE:BHC) Inc, the investment seriously harmed Ratan's performance in 2015.

Then, in December 2017, Chopra settled with the U.S. Securities and Exchange Commission over alleged inappropriate information-sharing with her husband, Paritosh Gupta, who worked at a different fund. Soon after, Robertson and other investors exited. Ratan now has $350 million in assets under management.

Whether last year's eye-popping performance translates into fresh cash remains to be seen. Since the financial crisis, investors have become increasingly skittish, often preferring big-name funds with smaller but steadier returns.

© Reuters. FILE PHOTO: A Specialist trader watches his chart while working on the floor of the New York Stock Exchange

In her letter, Chopra thanked investors who stuck with her over time, and warned that this year will likely be "bumpy."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.